Previous close | 92.43 |
Open | 92.43 |
Bid | 92.06 x 100 |
Ask | 100.12 x 200 |
Day's range | 91.86 - 92.68 |
52-week range | 73.10 - 96.44 |
Volume | |
Avg. volume | 275,593 |
Market cap | 3.009B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.64 |
Earnings date | 24 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 97.78 |
Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.
The headline numbers for Amedisys (AMED) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Amedisys (AMED) delivered earnings and revenue surprises of 1.98% and 1.21%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?